Inclusion Criteria:  Women over 18, Hospitalized or received in consultation for the management of hypertension treated in one of the hypertension and therapeutic, nephrology or cardiology departments participating in the study, with confirmed hypertension, treated with the following dosable antihypertensive agent(s): diltiazem, verapamil, acebutolol, atenolol, nébivolol, bisoprolol, metoprolol, propranolol, amiloride, furosemide, hydrochlorothiazide, indapamide, spironolactone, spironolactone , Lorsartan, Irbesartan, Ramipril, Perindopril, Amlodipine, Having signed the informed consent form. Beneficiary or affiliated to a French Social insurance  Exclusion Criteria:  Patients with bariatric surgery, Patients under guardianship/trusteeship/protection of justice, Patients with diagnosed and treated psychosis or depression, - Pregnant or nursing women.